Skip to content
stockresearch.app
RMD/History

ResMed (RMD) valuation history

Below its usual range

As of

RMD's EV/EBITDA of 16.8x is lower than 87% of its available weekly readings from the last five years.

EV/EBITDA weekly history9.6×20.1×30.5×41×Shading: 5-year middle halfMedian 22.1×16.8×202120232025
Share EV/EBITDA history
Preview embed

Chart by stockresearch.app. Reuse with credit under CC BY 4.0.

EV/EBITDA at year-end

Last weekly reading of each completed year. Rank runs from lowest (0%) to highest (100%) within the five years available on that date.

RMD year-end valuation history
Reading dateEV/EBITDA5-year rank
18.1×6%
21.6×12%
20.1×8%
26.7×35%
35.1×92%
31.3×93%
30.8×99%
23.3×77%
22.1×92%
17.7×Short history

Loading related research…

About this history

What is RMD's current EV/EBITDA?
RMD's EV/EBITDA of 16.8x is lower than 87% of its available weekly readings from the last five years.
What is RMD's five-year median EV/EBITDA?
The median, or middle weekly reading, is 22.1× over the last five years. Available history contains 533 weekly observations from Aug 8, 2016 to Oct 19, 2026.
Does a low historical rank mean a stock is a buy?
No. The rank describes a stock’s own history. Changes in growth, financial risk and the business can change the multiple investors pay. P/E uses earnings and P/S uses revenue from the previous twelve months.

Source: SEC company filings and weekly market prices. Multiples use the previous twelve months of financial results. Updated .

Read the valuation methodology